Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Natalie O'Donnell"'
Autor:
Annette Stemhagen, Youngsook Choi, Nora Tu, Zahid Islam, Natalie O'Donnell, Michele Julian, Maribel Salas, Mackenzie Henderson
Publikováno v:
Journal of Comparative Effectiveness Research. 10:953-967
Aim: Pexidartinib was approved for the treatment of tenosynovial giant cell tumors with a required Risk Evaluation and Mitigation Strategy (REMS) to ensure its safe use. As required by the REMS, a survey was conducted to document the knowledge, attit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc1767be29cdc1480e6f472abfe14e4
https://doi.org/10.2217/cer-2020-0253
https://doi.org/10.2217/cer-2020-0253
Autor:
Nora Tu, Annette Stemhagen, Maribel Salas, Michele Julian, Leonidas Drogaris, Natalie O'Donnell, Mackenzie Henderson, Zahidul Islam
Publikováno v:
Journal of Comparative Effectiveness Research. 10:187-192
Aim: Pexidartinib is approved in the USA for the treatment of symptomatic tenosynovial giant cell tumor associated with severe morbidity or functional limitations and not amenable to improvement with surgery. Due to risk of serious liver injury, a su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b2ab3d2d56b59d100df844051c0aad5
https://doi.org/10.2217/cer-2020-0147
https://doi.org/10.2217/cer-2020-0147
Autor:
Janet Pientka, Veronica Bainbridge, Monika Stender, Annette Stemhagen, Natalie O'Donnell, Carol E. Koro
Publikováno v:
Drugs-Real World Outcomes
Background The risk of pancreatitis and potential risk of medullary thyroid carcinoma associated with glucagon-like peptide-1 receptor agonists prompted the US Food and Drug Administration to require a Risk Evaluation and Mitigation Strategy for albi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c11f93b6182c105684addab96cb2a1
https://doi.org/10.1007/s40801-017-0128-3
https://doi.org/10.1007/s40801-017-0128-3
Autor:
Maribel Salas, Mackenzie Henderson, Michele Julian, Zahidul Islam, Leonidas Drogaris, Nora Tu, Natalie O'Donnell, Annette Stemhagen
Publikováno v:
Journal of Clinical Oncology. 38:e23580-e23580
e23580 Background: Pexidartinib, a kinase inhibitor, is approved for treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with sur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c813fd56fdaa93648e2436b0d07b6f1
https://doi.org/10.1200/jco.2020.38.15_suppl.e23580
https://doi.org/10.1200/jco.2020.38.15_suppl.e23580
Autor:
Cecilia K, Blomstedt, Roslyn M, Gleadow, Natalie, O'Donnell, Peter, Naur, Kenneth, Jensen, Tomas, Laursen, Carl Erik, Olsen, Peter, Stuart, John D, Hamill, Birger Lindberg, Møller, Alan D, Neale
Publikováno v:
Plant biotechnology journal. 10(1)
Cyanogenic glucosides are present in several crop plants and can pose a significant problem for human and animal consumption, because of their ability to release toxic hydrogen cyanide. Sorghum bicolor L. contains the cyanogenic glucoside dhurrin. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f98bd22881237b6579e975eb03586798
https://pubmed.ncbi.nlm.nih.gov/21880107
https://pubmed.ncbi.nlm.nih.gov/21880107
Autor:
WOOD, NATALIE O'DONNELL
Publikováno v:
State Legislatures. Oct/Nov2011, Vol. 37 Issue 9, p34-35. 2p.
Autor:
WOOD, NATALIE O'DONNELL
Publikováno v:
State Legislatures. Jul/Aug2011, Vol. 37 Issue 7, p44-44. 3/4p.